支气管扩张患者抗菌药物雾化吸入治疗进展研究

Research Progress in the Treatment of Bronchiectasis Patients with Antimicrobial Aerosol Inhalation

支气管扩张症属于临床中发生率较高的慢性气道炎症性疾病之一,是一系列病因引起的支气管树出现病理性扩张、变形,人群不同、地域不同,支气管扩张症的发病原因也存在差异,例如反复肺部感染、风湿性疾病、免疫功能缺陷等。支气管扩张症患者临床症状主要为长时间咳嗽,反复咯血、咳脓痰;患者常常因为疾病反复的急性加重而就医,不仅会消耗大量的医疗资源,而且疾病自身也会对患者身心健康造成严重威胁,降低其生活质量,因此及时选择科学和合理的方法来治疗支气管扩张症就显得非常重要。现阶段临床中在对支气管扩张症患者进行治疗时,最关键的环节就是控制感染。本文主要分析了支气管扩张症患者采用抗菌药物雾化吸入治疗的进展,希望能为防治支气管扩张症提供参考。

Bronchiectasis is one of the chronic airway inflammatory diseases with high incidence in clinic,which is pathological expansion and deformation of the bronchial tree caused by a series of causes.The causes of bronchiectasis are also different in different populations and regions,such as repeated pulmonary infections,rheumatic diseases,im-mune function defects,etc.The main clinical symptoms of patients with bronchiectasis were long-term cough,repeated hemoptysis and expectoration.Patients often seek medical treatment because of repeated acute exacerbations of the dis-ease,which will not only consume a lot of medical resources,but also cause serious threats to the physical and mental health of patients and reduce their quality of life.Therefore,it is very important to choose scientific and reasonable meth-ods to treat bronchiectasis in time.At this stage of clinical treatment for patients with bronchiectasis,the most critical link is to control infection.This paper mainly analyzes the progress of the treatment of bronchiectasis patients with antimicro-bial aerosol inhalation,hoping to provide reference for the prevention and treatment of bronchiectasis.